摘要
登革病毒是一种危害较严重的病原体 ,在世界范围内的流行颇为频繁 ,然而目前仍设有安全有效的疫苗。近年来 ,人们对传统疫苗 (灭活疫苗、减毒疫苗和亚单位疫苗 )及新型疫苗 (cDNA疫苗、嵌合体疫苗和DNA疫苗 )的研究已取得了一定的成果。
出处
《微生物学免疫学进展》
2001年第1期74-77,共4页
Progress In Microbiology and Immunology
参考文献25
-
1[1]Pumak R, Barvir DA, Burrous JM, et al. Development of a purified, inactivated, dengue-2 virus vaccine prototype in Vero cell Immunogencity and protection in mice and Rhesus monkeys[ J ]. J Infcet Dis 1996,174(6): 1184.
-
2[2]Putnak R,Cassidy K,Conforti N,et al.Immunogenic and protective response in mice immunized with a purified, inactivated,dengue-2 virus vaccine prototype made in fetal Rhesus lung cells [J]. Am.J. Trop. Med Hyg 1996,55(5) :504-510.
-
3[3]VelzingJ, Groen J, Drouet MT, et al. Induction of protective immunity against dengue viruses type 2: comparison of candidate live attenuated and recombinant vaccines[J]. Vaccine 1999,17:1312-1320.
-
4[4]Vaughn DW,Jr CHH,Yoksan S,et al. Testing of a dengue 2 liveattenuated vaccine (strain 16681 PDK53 ) in ten American volunteers[J]. Vaccine 1996,14(4): 329-336.
-
5[5]Chambers TJ,Tsai TF, Pervikov Y,et al. Vaccine development against dengue and Japanese encephalitis: report of a World Health Organization meeting[J]. Vaccine 1997,15(14): 1494-1502.
-
6[6]Schlesinger JJ, Brandriss MW, Walsh EE. Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus nonstructural glycoprotein NS1 [J]. J Gen Virol 1987,68: 853-857.
-
7[7]Huang JH, Wey JJ, Sun YC, et al. Antibody responses to an immunodominant nonstructural 1 synthetic peptide in patients with dengue fever and dengue hemorrhagic fever[J]. Med. Virol 1999,57:1-8.
-
8[8]Fonseca BAL, Khoshnood K,Shope RE, et al. Flavivirus type-specific antigens produced from fusion of a prrtion of the E pritein with the E. Coli tripe gene[J]. Am. J. Trop. Med. Hyg 1991,44:500-508.
-
9[9]Simmons M, Nelson WM,Wu SJL, et al. Evaluation of the protective efficacy of a recombinant denue envelope B domain fusion pretein against dengue 2 virus infection in mice[J]. Am. J. Trop.Med. Hyg, 1998,58(5) :655-662.
-
10[10]Ohrnann H,Beasley DWC,Fitzpatrick DR,et al. Analsis of a recombinant dengue-2 virus-dengue-3 virus hybrid envelope protein expressed in a secretory baculovirus system [J]. J. Gen Virol 1997.78: 2723-2733.
同被引文献49
-
1Putnak R, Cassidy K, Conforti N, et al. Immunogenic and protective response in mice immunized with a purified, inactivated, dengue-2 virus vaccine prototype made in fetal rhesus lung cells [J]. Am J Trop Med Hyg, 1996, 55(5) :504-510.
-
2Robert Putnak J, Coller BA, Voss G, et al. An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model [J]. Vaccine, 2005, 23(35): 4442-4452.
-
3Guzman MA, Rodriguez RA, Rodriguez RO, et al. Induction of neutralizing antibodies and partial protection from viral challenge in Macaea fascicularis immunized with recombinant dengue 4 virus envelope glycoprotein expressed in Pichia pastoris [J]. Am J Trop Med Hyg, 2003, 69(2) :129-134.
-
4Raviprakash K, Porter KR, Kochel TJ, et al. Dengue virus type 1 DNA vaccine induces protective immune responses in rhesus macaques [J]. J Gen Virol, 2000, 81(7) :1659-1667.
-
5Cook S, Holmes EC. A multigene analysis of the phylogenetic relationships among the flaviviruses ( Family : Flaviviridae) and the evolution of vector transmission [J]. Arch Virol, 2006, 151 (2) :309-325.
-
6Gubler D J, Meltzer M. Impact of dengue/dengue hemorrhagic fever on the developing world [J]. Adv Virus Res, 1999, 53 : 35 -70.
-
7Pinheiro FP, Corber SJ. Global situation of dengue and dengue haemorrhagic fever, and its emergence in the Americas [J]. World Health Stat Q, 1997, 50(3/4) :161-169.
-
8Gubler DJ. Dengue and dengue hemorrhagic fever [J]. Clin Microbiol Rev, 1998, 11 (3) :480-496.
-
9World Health Organization. Dengue haemorrhagic fever: diagnosis, treatment, prevention and control [M]. 2nd ed. Geneva : World Health Organization, 1997.
-
10世界卫生组织.登革热和登革出血热[EB/OL].[2008-10-22].http://www.who.int/mediacentre/factsheets/fs117/zh/index.html.
二级引证文献2
-
1孟胜利(综述),孙燕(综述).登革病毒E蛋白结构域Ⅲ疫苗研究进展[J].国际生物制品学杂志,2011,34(2):72-76. 被引量：1
-
2刘晓宇,姚立红,陈爱珺,郭建强,张智清,陈辉.昆虫杆状病毒系统表达登革2型病毒prM/E蛋白[J].中国医学装备,2014,11(5):52-55. 被引量：2
-
1赵东赤,邹典定,张楚瑜.呼吸道合胞病毒疫苗的研究和临床应用[J].国外医学（儿科学分册）,2002,29(2):94-97. 被引量：2
-
2刘杰,杨继勇.病毒样颗粒疫苗的研究进展及其在传染病防控中的应用前景[J].中华检验医学杂志,2014,37(10):739-742.
-
3冯志华,白宪光,周永兴,贾战生,李谨革,杜德伟.两种HCV不同结构基因重组质粒DNA诱导免疫应答的比较研究[J].细胞与分子免疫学杂志,2001,17(2):143-145.
